Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.
about
Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesPI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell linesA phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumorsStromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia.Dual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells.Akt Inhibitor Perifosine Prevents Epileptogenesis in a Rat Model of Temporal Lobe Epilepsy.Targeting the mTOR Pathway in Leukemia.Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.Network dynamics-based cancer panel stratification for systemic prediction of anticancer drug response.MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma.
P2860
Q28081001-39C23059-5601-4D7D-BB26-8128307DB91AQ33618630-6CB9D105-6ED5-4A68-9AB9-EF7EA770DDE1Q33764664-E39746C4-D9A9-4BD2-8A1C-784D9ED6CE20Q36619115-89251195-8F68-47D4-B86C-874E17B47194Q37635839-337F170D-5FD1-4F2D-9AA6-3005DFC727CBQ38635465-8FAB8B32-7A2E-4146-838D-F3BAD7C9C6FFQ38790630-60747CA5-6421-4764-BC5F-B2874B8BF49FQ38856941-8101AF74-CE8B-491B-A064-EA2CC9430982Q42317505-79EB4499-43D9-4124-A390-8C667270D9F6Q47110143-3B13C3B8-15DE-436E-8B5E-81B181B773EEQ47155414-F6BCB984-E286-4452-AA61-08045075ED21Q49547726-346E1EC0-A777-4463-9CF2-396A6C99CAAA
P2860
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Triple Akt inhibition as a new ...... acute lymphoblastic leukemia.
@en
Triple Akt inhibition as a new ...... acute lymphoblastic leukemia.
@nl
type
label
Triple Akt inhibition as a new ...... acute lymphoblastic leukemia.
@en
Triple Akt inhibition as a new ...... acute lymphoblastic leukemia.
@nl
prefLabel
Triple Akt inhibition as a new ...... acute lymphoblastic leukemia.
@en
Triple Akt inhibition as a new ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1433
P1476
Triple Akt inhibition as a new ...... acute lymphoblastic leukemia.
@en
P2093
Alberto M Martelli
Carolina Simioni
Giorgio Zauli
Giovanna Tabellini
James A McCubrey
Luca M Neri
Simona Ultimo
P2860
P304
P356
10.18632/ONCOTARGET.3260
P407
P577
2015-03-01T00:00:00Z